Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Bonus plan approved
Inv. presentation
Acq. announced
Director departure
|
|
CUBIST PHARMACEUTICALS INC (CBST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/21/2015 |
8-K
| Quarterly results |
| 01/13/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/02/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/22/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/19/2014 |
8-K
| Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Financial Statements and Exhibits |
| 12/09/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/08/2014 |
8-K
| Bonus plan approved/adopted |
| 11/06/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/22/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/21/2014 |
8-K
| Quarterly results |
| 08/11/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/06/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/22/2014 |
8-K
| Quarterly results |
| 07/14/2014 |
8-K
| Entry into a Material Definitive Agreement |
| 06/23/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/04/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 06/02/2014 |
8-K
| Other Events |
| 04/22/2014 |
8-K
| Quarterly results |
| 04/01/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/28/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/21/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/23/2014 |
8-K
| Quarterly results |
| 01/13/2014 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits |
| 12/16/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/26/2013 |
8-K
| Other Events |
| 11/25/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/24/2013 |
8-K
| Form 8-K - Current report |
| 10/22/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/22/2013 |
8-K
| Quarterly results |
| 09/10/2013 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Indenture, between Cubist Pharmaceuticals, Inc. and the Bank of New York Mellon Trust Company, N.A. (including the form of the 1.125% Convertible Senior Note due 2018)",
"Indenture, between Cubist Pharmaceuticals, Inc. and the Bank of New York Mellon Trust Company, N.A. (including the form of the 1.875% Convertible Senior Note due 2020)",
"Additional convertible bond hedge transaction confirmation, by and between Morgan Stanley & Co. International plc and Cubist Pharmaceuticals, Inc., in reference to the 1.125% Convertible Senior Notes due 2018",
"Additional convertible bond hedge transaction confirmation, by and between Barclays Bank PLC and Cubist Pharmaceuticals, Inc., in reference to the 1.125% Convertible Senior Notes due 2018",
"Additional convertible bond hedge transaction confirmation, by and between Royal Bank of Canada and Cubist Pharmaceuticals, Inc., in reference to the 1.125% Convertible Senior Notes due 2018",
"Additional issuer warrant transaction confirmation, by and between Morgan Stanley & Co. International plc and Cubist Pharmaceuticals, Inc., in reference to the 1.125% Convertible Senior Notes due 2018",
"Additional issuer warrant transaction confirmation, by and between Barclays Bank PLC and Cubist Pharmaceuticals, Inc., in reference to the 1.125% Convertible Senior Notes due 2018",
"Additional issuer warrant transaction confirmation, by and between Royal Bank of Canada and Cubist Pharmaceuticals, Inc., in reference to the 1.125% Convertible Senior Notes due 2018",
"Additional convertible bond hedge transaction confirmation, by and between Morgan Stanley & Co. International plc and Cubist Pharmaceuticals, Inc., in reference to the 1.875% Convertible Senior Notes due 2020",
"Additional convertible bond hedge transaction confirmation, by and between Barclays Bank PLC and Cubist Pharmaceuticals, Inc., in reference to the 1.875% Convertible Senior Notes due 2020" |
|
| 09/03/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/29/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/01/2013 |
8-K
| Investor presentation|
Docs:
|
"Agreement and Plan of Merger, among Cubist Pharmaceuticals, Inc., BRGO Corporation and Trius Therapeutics, Inc. Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Form of Contingent Value Rights Agreement, to be entered into between Cubist Pharmaceuticals, Inc. and Broadridge Corporate Issuer Solutions, Inc",
"Form of Tender and Voting Agreement, by and among Cubist Pharmaceuticals, Inc. and the directors and certain officers of Trius Therapeutics, Inc. and their stockholder affiliates",
"Investor Presentation Slideshow, July 30, 2013" |
|
| 07/30/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|